The chemical substance known as 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one, with the CAS number 126128-41-4, is a complex organic compound characterized by its unique structural features. It contains a pyrimidine ring fused to an oxazine moiety, which contributes to its potential biological activity. The presence of the β-D-2-deoxyribofuranosyl group suggests that it may interact with nucleic acids or related biomolecules, possibly influencing processes such as DNA or RNA synthesis. The di-O-(p-toluoyl) substituents indicate that the compound may exhibit lipophilic properties, potentially affecting its solubility and permeability in biological systems. This compound may be of interest in medicinal chemistry, particularly in the development of nucleoside analogs or other therapeutic agents. Its specific reactivity, stability, and biological interactions would require further investigation through experimental studies to elucidate its full potential and applications in pharmaceutical research.

6-(3,5-DI-O-(P-TOLUOYL)-BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO[4,5-C][1,2]OXAZIN-7-ONE

126128-41-4: The chemical substance known as 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one, with the CAS number 126128-41-4, is a complex organic compound characterized by its unique structural features. It contains a pyrimidine ring fused to an oxazine moiety, which contributes to its potential biological activity. The presence of the β-D-2-deoxyribofuranosyl group suggests that it may interact with nucleic acids or related biomolecules, possibly influencing processes such as DNA or RNA synthesis. The di-O-(p-toluoyl) substituents indicate that the compound may exhibit lipophilic properties, potentially affecting its solubility and permeability in biological systems. This compound may be of interest in medicinal chemistry, particularly in the development of nucleoside analogs or other therapeutic agents. Its specific reactivity, stability, and biological interactions would require further investigation through experimental studies to elucidate its full potential and applications in pharmaceutical research.

<p>6-(2-Deoxy-3,5-di-O-toluoyl-b-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one is a nucleoside analog that inhibits the activity of DNA polymerase and RNA polymerase. It has been shown to be active against human leukemia cells and is currently being used in clinical trials for cancer treatment. 6-(2-Deoxy-3,5-diOtoluoyl b D ribofuranosyl)-3,4 dihydro 8H pyrimido[4,5 c] [1,2]oxazin 7 one is a novel nucleoside analog that has been shown to be effective against both DNA and RNA viruses.</p>

CAS 126128-41-4

6-(3,5-DI-O-(P-TOLUOYL)-BETA-D-2-DEOXYRIBOFURANOSYL)-3,4-DIHYDRO-8H-PYRIMIDO[4,5-C][1,2]OXAZIN-7-ONE

6-(2-Deoxy-3,5-di-O-toluoyl-b-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one

Ref: 3D-ND145588